Publications by authors named "Thomas Pennington"

Claim this Profile
O
Oncoplastic surgery for cutaneous head and neck cancers: A novel technique combining wide excision, local flap reconstruction and sentinel node biopsy.
Caroline A Gjorup, Michael Chae, Terence Wong, David J Coker, Thomas E Pennington

JPRAS Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma.
Andrea Boutros, Amelia M Taylor, Isabel Li, Nurudeen A Adegoke, Terence Wong, Thomas Pennington

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node-positivity in melanoma patients.
John F Thompson, Roger F Uren, Kevin London, David Chung, Robyn Pm Saw, Thomas E Pennington

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort.
Jorja Braden, Alison Potter, Robert V Rawson, Nurudeen A Adegoke, Serigne N Lo, Thomas E Pennington

Mod Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator.
Thomas E Pennington, John F Thompson, Robyn P M Saw, David J Coker, Serigne N Lo

Ann Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cartilage Resection in the Surgical Management of Ear Melanoma.
Elan Novis, Joyce Tan, Danielle Vignati, Terence Wong, Robert V Rawson, Thomas E Pennington

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?
Thomas E Pennington, John F Thompson, Alex H R Varey

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to Surgical Management of Anorectal Melanoma in the Pre- and Post-Immunotherapy Eras.
James A Pasch, Wendy S Liu, Shahrir Kabir, Thomas E Pennington

Dis Colon Rectum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incarcerated lateral inguinal hernia following ilioinguinal lymph node dissection: an unusual case.
Mansha Jiwane, Elan Novis, Emily C Smartt, Thomas E Pennington

J Surg Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, Zeynep Eroglu, Shahneen Sandhu, Thomas E Pennington

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patients.
Elan Novis, Ahmad Sulaiman, Jonathan Stretch, David Chung, Kevin London, Thomas E Pennington

Eur J Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on Dixon et al. Primary Cutaneous Melanoma-Management in 2024. 2024, , 1607.
Thomas E Pennington, John F Thompson

J Clin Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous collision metastasis of melanoma and squamous cell carcinoma in a parotid lymph node: a very rare occurrence and literature review.
Michelle Wu, Nigel Maher, Richard A Scolyer, Alexander M Menzies, Thomas E Pennington

Pathology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods Study.
Kathy Dempsey, Robyn Saw, Iris Bartula, Serigne N Lo, Alexander M Menzies, Thomas Pennington

Psychooncology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
Christian U Blank, Minke W Lucas, Richard A Scolyer, Bart A van de Wiel, Alexander M Menzies, Thomas E Pennington

N Engl J Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.
Georgina V Long, Matteo S Carlino, George Au-Yeung, Andrew J Spillane, Kerwin F Shannon, Thomas E Pennington

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Lisanne P Zijlker, Henry Chen, Andrew J Spillane, Maria Gonzalez, Thomas E Pennington

Ann Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Alec A Winder, Zoe Boyer, Sydney Ch'ng, Jonathan R Stretch, Robyn P M Saw, Thomas E Pennington

Ann Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, Julie Simon, Aikaterini Dedeilia, Thomas E Pennington

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Caroline A Gjorup, Rachel Woodford, Isabel Li, Matteo S Carlino, Sydney Ch'ng, Thomas E Pennington

Ann Surg Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic predictions and precautionary preparations: lessons from history.
Thomas H Pennington

Future Microbiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unicentric Castleman's disease imitating metastatic melanoma: A case report.
Oliver Chow, Elizabeth Robbins, Rony Kapur, Thomas E Pennington

Int J Surg Case Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study.
Kathy Dempsey, Robyn Saw, Iris Bartula, Serigne Lo, Craig Lawn, Thomas Pennington

BMJ Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, Charlotte Ariyan, Paolo A Ascierto, Thomas E Pennington

Ann Surg Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.
Irene L M Reijers, Alexander M Menzies, Alexander C J van Akkooi, Judith M Versluis, Noëlle M J van den Heuvel, Thomas E Pennington

Nat Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis